Group A streptococcus is a strict human pathogen that can cause a wide range of diseases, such as tonsillitis, impetigo, necrotizing fasciitis, toxic shock, and acute rheumatic fever. Modeling human diseases in animals is complicated, and rapid, simple, and cost-effective in vivo models of GAS infection are clearly lacking. Recently, the use of non-mammalian models to model human disease is starting to re-attract attention. Galleria mellonella larvae, also known as wax worms, have been investigated for modeling a number of bacterial pathogens, and have been shown to be a useful model to study pathogenesis of the M3 serotype of GAS. In this study we provide further evidence of the validity of the wax worm model by testing different GAS M-types, as well as investigating the effect of bacterial growth phase and incubation temperature on GAS virulence in this model. In contrast to previous studies, we show that the M-protein, among others, is an important virulence factor that can be effectively modeled in the wax worm. We also highlight the need for a more in-depth investigation of the effects of experimental design and wax worm supply before we can properly vindicate the wax worm model for studying GAS pathogenesis.
Group A streptococcus is a strict human pathogen that can cause a wide range of diseases, such as tonsillitis, impetigo, necrotizing fasciitis, toxic shock, and acute rheumatic fever. Modeling human diseases in animals is complicated, and rapid, simple, and cost-effective in vivo models of GAS infection are clearly lacking. Recently, the use of non-mammalian models to model human disease is starting to re-attract attention. Galleria mellonella larvae, also known as wax worms, have been investigated for modeling a number of bacterial pathogens, and have been shown to be a useful model to study pathogenesis of the M3 serotype of GAS. In this study we provide further evidence of the validity of the wax worm model by testing different GAS M-types, as well as investigating the effect of bacterial growth phase and incubation temperature on GAS virulence in this model. In contrast to previous studies, we show that the M-protein, among others, is an important virulence factor that can be effectively modeled in the wax worm. We also highlight the need for a more in-depth investigation of the effects of experimental design and wax worm supply before we can properly vindicate the wax worm model for studying GAS pathogenesis.
Entities:
Keywords:
Galleria mellonellalarvae; Streptococcus pyogenes; group A streptococcus; in vivo; infection model; wax worms
Group A streptococcus (GAS, Streptococcus pyogenes) is a human pathogen responsible for a diverse range of infections from uncomplicated pharyngitis and tonsillitis to more severe and life threatening diseases such as necrotizing fasciitis., It is estimated that over 500 000 deaths are caused by GAS each year. GAS expresses a wide array of virulence factors that are required for colonization, invasion, and immune evasion of the human host.- One of the best characterized is the M-protein, a cell wall anchored protein that facilitates adhesion to host cells and inhibits phagocytosis by host neutrophils., Isogenic knockouts of the M-protein have shown reduced virulence in murine models of infection., The M-protein is encoded by the emm gene, of which there are over 100 types known., Different M-types have been associated with particular clinical syndromes. For example, M1 and M3 are associated with severe invasive disease, while M18 is associated with ARF.- However, the same M-types are also commonly isolated from non-invasive diseasepatients and carriers suggesting that there may be a larger reservoir of these M-types in the population and that the dynamic interplay between pathogen and host is what ultimately determines the outcome of infection.,The ability of GAS to sense its microenvironment and respond accordingly warrants the in vivo analysis of pathogenicity to better understand and dissect pathways involved in virulence. However, because GAS is a strict human pathogen it will always be difficult to accurately model disease in animals. Despite this there are a number of well-established models of GAS infection in mice and monkeys that have proven to be invaluable tools for dissecting events involved in GAS infection and the dynamics between pathogen and host.- However, with the growing costs and ethical considerations involved with mammalian models, the use of non-mammalian models of infection is starting to re-attract attention.The classic non-mammalian model organisms used for biological research are the nematode, Caenorhabditis elegans, and the common fruit fly, Drosophila melanogaster.- Both share many advantages over mammalian models in that they are easy to obtain and convenient to use, cost-effective, and more ethically acceptable. Death as an endpoint in experiments is also able to be used, which is unacceptable for mammalian models in many countries, including New Zealand. Recently, interest in the larvae of the wax moth, Galleria mellonella (also known as the wax worm), has been gaining momentum and a number of groups have investigated its use for modeling bacterial and fungal infections.- The main advantage the wax worm model has over C. elegans and D. melanogaster is their ability to survive at 37 °C. This is particularly important when studying human pathogens, including GAS, that naturally persist at human body temperatures. The immune system of the wax worm shares functional homology with the innate immune systems of mammals and possesses both humoral and cellular immunity., Importantly, wax worms have hemocytes which are very similar to mammalian phagocytic cells, and are capable of engulfing pathogenic bacteria and killing them by respiratory burst. Recently, Olsen et al. validated the use of wax worms as an infection model for the M3-type of GAS. In this study, we further validate the use of the wax worm infection model by using not only the M3-type of GAS, but multiple other serotypes of GAS as well. The effects of bacterial growth stage and incubation temperature were also investigated. In addition, we also show that mutants of the M1-type with attenuated virulence can be successfully modeled in the wax worm.
Results
Establishment of the wax worm model for M1 GAS (SF370) infection
To determine the pathogenicity of a M1-serotype of GAS (SF370) in wax worms, a dose titration was performed with stationary phase cultures ranging from 1 × 104 colony forming units (CFU) to 2 × 107 CFU. Groups of 10 wax worms were infected through their lower left proleg with each dose of GAS M1 SF370 or PBS control. PBS control injected larvae all remained alive over the 5 d time course (Fig. 1A). In contrast, GAS-infected wax worms were killed rapidly resulting in 100% death after 1 d at doses above 6.7 × 106 CFU (Fig. 1A). Survival curves correlated with inoculum dose, with greater number of deaths observed at higher doses (Fig. 1A). Inoculums below 8 × 104 CFU were no longer lethal (data not shown). In order to obtain more subtle differences in larvae health status, each wax worm was also scored according to 4 major observations: activity, cocoon formation, melanization, and survival. Higher activity and more cocoon formation correspond to a healthier wax worm. Production of melanin by the wax worm also occurs as a result of an immune response against infection, as melanin aids to trap and kill pathogens. Typically complete melanization (a sign that the immune response has been overwhelmed) correlates with death of the wax worm soon after. A score was assigned to each observation and an overall health index score was calculated for each wax worm. Increasing health index scores correlated well with increasing inoculum dose, and day 1 health index scores reflected the final outcome of wax worms at day 5 (Fig. 1B and D).
Figure 1. Virulence of different growth phases of M1 GAS in wax worms. Wax worms were inoculated with a dose titration of fresh stationary (St) phase, fresh exponential (Exp) phase, or pre-frozen exponential phase M1 GAS and monitored daily for 5 d. (A) Kaplan-Meier survival curves of wax worms infected with a dose titration of stationary phase M1 GAS. *P < 0.05 (log-rank). (B) Mean ± SEM health index scores of wax worms infected with a dose titration of stationary phase M1 GAS. *P < 0.05 (2-way ANOVA). (C) Nonlinear regression of wax worm death on day 1 post-infection with a dose titration of stationary or exponential phase cultures of M1 GAS. (D) Mean ± SEM health index scores of wax worms 1 d post-infection with a dose titration of stationary or exponential phase cultures of M1 GAS.
Figure 1. Virulence of different growth phases of M1 GAS in wax worms. Wax worms were inoculated with a dose titration of fresh stationary (St) phase, fresh exponential (Exp) phase, or pre-frozen exponential phase M1 GAS and monitored daily for 5 d. (A) Kaplan-Meier survival curves of wax worms infected with a dose titration of stationary phase M1 GAS. *P < 0.05 (log-rank). (B) Mean ± SEM health index scores of wax worms infected with a dose titration of stationary phase M1 GAS. *P < 0.05 (2-way ANOVA). (C) Nonlinear regression of wax worm death on day 1 post-infection with a dose titration of stationary or exponential phase cultures of M1 GAS. (D) Mean ± SEM health index scores of wax worms 1 d post-infection with a dose titration of stationary or exponential phase cultures of M1 GAS.The metabolic state of bacteria is known to affect their pathogenicity due to the regulation of expressed virulence factors.- To test if the growth phase of bacteria has any effect on virulence toward wax worms, M1 GAS was grown to exponential phase prior to injection. In addition, cultures were also frozen at exponential phase and thawed at the time of inoculation to determine the effect of storage on bacterial virulence. Fresh exponential phase cultures were more virulent than frozen exponential phase cultures with lower health index scores (Fig. 1D) and lower day 1 LD50 concentrations of 2.9 × 106 CFU/wax worm and 6 × 106 CFU/wax worm, respectively (Fig. 1C). The higher virulence observed with fresh cultures is expected due to its greater metabolically active state prior to inoculation. Surprisingly however, fresh exponential phase cultures were ~3-fold less virulent than fresh stationary phase cultures of GAS (Fig. 1C). Although a number of virulence factors are known to be differentially expressed during exponential and stationary phase cultures, many cell-wall associated factors are more highly expressed during early growth stages while secreted virulence factors tend to have higher expression during later growth stages. To test if secreted virulence factors are involved in the enhanced virulence of stationary phase GAS, filtered supernatants from either fresh exponential phase or fresh stationary phase cultures were injected directly into wax worms and monitored for toxicity. Complete survival and high health index scores of wax worms were observed with both exponential phase supernatants and media controls (Fig. 2). In contrast, wax worms injected with stationary phase supernatants showed a rapid decline in health and survival (Fig. 2). This toxicity seen with stationary phase supernatants was negated when supernatants were heat-treated prior to injection (Fig. 2).
Figure 2. Toxicity of exponential or stationary phase supernatants of M1 GAS in wax worms. M1 GAS was grown to exponential or stationary phase and supernatants collected and filter sterilized prior to injection. Where indicated, heat-inactivation of supernatant was performed at 60 °C for 1 h prior to injection. (A) Kaplan-Meier survival curves of wax worms injected with exponential phase supernatant (squares), stationary phase supernatant (triangles), heat-inactivated stationary phase supernatant (diamonds), or media alone (circles). *P < 0.05 (log-rank). (B) Mean ± SEM health index scores of wax worms injected with exponential phase supernatant (squares), stationary phase supernatant (triangles), heat-inactivated stationary phase supernatant (diamonds), or media alone (circles). *P < 0.05 (2-way ANOVA).
Figure 2. Toxicity of exponential or stationary phase supernatants of M1 GAS in wax worms. M1 GAS was grown to exponential or stationary phase and supernatants collected and filter sterilized prior to injection. Where indicated, heat-inactivation of supernatant was performed at 60 °C for 1 h prior to injection. (A) Kaplan-Meier survival curves of wax worms injected with exponential phase supernatant (squares), stationary phase supernatant (triangles), heat-inactivated stationary phase supernatant (diamonds), or media alone (circles). *P < 0.05 (log-rank). (B) Mean ± SEM health index scores of wax worms injected with exponential phase supernatant (squares), stationary phase supernatant (triangles), heat-inactivated stationary phase supernatant (diamonds), or media alone (circles). *P < 0.05 (2-way ANOVA).Although higher virulence was achieved using fresh cultures of GAS, to enable better comparison with previously published work on the M3-serotype of GAS in wax worms, the remainder of experiments were performed with frozen exponential phase cultures.
Kinetics of bacterial growth in vivo
To determine the kinetics of bacterial growth in vivo, wax worms were infected with a lethal dose of M1 GAS. At each time point, individual wax worms were homogenized in PBS and plated for bacterial enumeration. As expected, bacterial numbers increased over time until reaching what seems to be a critical value that causes death of the wax worm between 108 and 109 CFU (Fig. 3). By 12 h there were no longer any surviving wax worms; however, bacteria were able to continue to survive within the dead wax worm for at least a further 12 h (Fig. 3). To ensure that the bacteria recovered from these wax worms were GAS, a spectinomycin-resistant mutant of GASSF370 was tested in a similar manner. In absence of GAS infection, there was a baseline level of natural flora recovered from wax worms that were able to grow on BHI agar, but not BHI agar containing spectinomycin (). However, the growth of natural flora was quickly overtaken when the spectinomycin-resistant GAS was injected, so that the majority of bacteria that were recovered from these wax worms were GAS. This was shown by the similar bacterial counts recovered on BHI vs. BHI/spectinomycin agar (). In vivo growth kinetics of the spectinomycin-resistant GAS was similar to WT GAS.
Figure 3. Kinetics of M1 GAS bacterial growth in vivo. Wax worms were inoculated with a lethal dose of M1 GAS. At each time point, wax worms were homogenized in 0.5 ml PBS and β-hemolytic bacteria enumerated by plating on blood agar. Each symbol represents bacterial counts obtained from an individual wax worm. Closed circles represent wax worms that were still alive, open circles represent wax worms that were dead. Line indicates the mean ± SEM.
Figure 3. Kinetics of M1 GAS bacterial growth in vivo. Wax worms were inoculated with a lethal dose of M1 GAS. At each time point, wax worms were homogenized in 0.5 ml PBS and β-hemolytic bacteria enumerated by plating on blood agar. Each symbol represents bacterial counts obtained from an individual wax worm. Closed circles represent wax worms that were still alive, open circles represent wax worms that were dead. Line indicates the mean ± SEM.
The effect of incubation temperature on GAS virulence
The effect of incubation temperature on GAS virulence was tested by maintaining wax worms at either 28 °C or 37 °C post-infection. Temperature did not affect the survival of wax worms injected with the PBS control (Fig. 4A and B). However, dropping the temperature had a minor effect on wax worms injected with M1 GAS by delaying death at higher inoculums (Fig. 4A and B). There was no significant difference in survival at inoculums 3.3 × 106 CFU and below (data not shown). Day 1 LD50 values were approximately 2-fold higher in wax worms maintained at 28 °C (6.9 × 106 CFU/wax worm) compared with wax worms maintained at 37 °C (3.6 × 106 CFU/wax worm) (Fig. 4C) and significant differences in day 1 health index scores were only observed at 1 × 107 CFU (Fig. 4D).
Figure 4. The effect of incubation temperature on GAS virulence. Wax worms were infected with a dose titration of M1 GAS then maintained at either 28 °C or 37 °C. (A) Kaplan-Meier survival curves of wax worms infected with 1 × 107 CFU M1 GAS/wax worm. *P < 0.05 (log-rank). (B) Kaplan-Meier survival curves of wax worms infected with 3 × 107 CFU M1 GAS/wax worm. *P < 0.05 (log-rank). (C) Nonlinear regression of wax worm death at day 1 post-infection at 28 °C (triangles) or 37 °C (squares). (D) Mean ± SEM day 1 health index scores of wax worms maintained at either 28 °C (triangles) or 37 °C (squares). *P < 0.05 (t-test).
Figure 4. The effect of incubation temperature on GAS virulence. Wax worms were infected with a dose titration of M1 GAS then maintained at either 28 °C or 37 °C. (A) Kaplan-Meier survival curves of wax worms infected with 1 × 107 CFU M1 GAS/wax worm. *P < 0.05 (log-rank). (B) Kaplan-Meier survival curves of wax worms infected with 3 × 107 CFU M1 GAS/wax worm. *P < 0.05 (log-rank). (C) Nonlinear regression of wax worm death at day 1 post-infection at 28 °C (triangles) or 37 °C (squares). (D) Mean ± SEM day 1 health index scores of wax worms maintained at either 28 °C (triangles) or 37 °C (squares). *P < 0.05 (t-test).
Attenuated virulence mutants of M1 GAS can be monitored in the wax worm model
One of the potential uses of the wax worm model could be to screen novel genetic mutations for altered phenotypes. As proof of principle, we took two known virulence factors of GAS and created isogenic knockout mutants using a gene replacement strategy. Complemented strains were also created for each knockout mutant to reintroduce the full length gene in a constitutively active plasmid. M-protein is an important and well characterized virulence factor that has many functions including adhesion and immune evasion. Wax worms inoculated with the M-protein knockout mutant (ΔM1) had enhanced survival and higher health index scores compared with wax worms inoculated with WT GAS (Fig. 5). Complementing the knockout mutant with the full-length emm gene (ΔM1+M1) restored the survival rate and health status to levels comparable to WT (Fig. 5). These results were reflected by the day 1 LD50 values which were 6 × 106 CFU for WT, 7.6 × 106 CFU for ΔM1+M1, and 1.7 × 107 CFU for ΔM1 (Fig. 5C). Bacteria recovered from wax worms over the first 24 h suggested that reduced virulence of the M-protein knockout mutant may be due to a reduction in replication/survival rate as shown by a shift to the right of the in vivo growth kinetic curve compared with WT ().
Figure 5. Knockout of M-protein in M1 GAS reduces virulence in the wax worm model. Wax worms were inoculated with a dose titration of WT (circles), M-protein knockout (squares), or M-protein complemented (triangles) GAS and monitored daily for 5 d. (A) Kaplan-Meier survival curves at an inoculum of 7.5 × 106 CFU/wax worm. *P < 0.05 (log-rank test). (B) Mean ± SEM health index scores of wax worms post-infection with 7.5 × 106 CFU/wax worm. *P < 0.05 (2-way ANOVA). (C) Nonlinear regression of wax worm death at day 1 post-infection. (D) Mean health ± SEM index scores of wax worms at day 1 post-infection.
Figure 5. Knockout of M-protein in M1 GAS reduces virulence in the wax worm model. Wax worms were inoculated with a dose titration of WT (circles), M-protein knockout (squares), or M-protein complemented (triangles) GAS and monitored daily for 5 d. (A) Kaplan-Meier survival curves at an inoculum of 7.5 × 106 CFU/wax worm. *P < 0.05 (log-rank test). (B) Mean ± SEM health index scores of wax worms post-infection with 7.5 × 106 CFU/wax worm. *P < 0.05 (2-way ANOVA). (C) Nonlinear regression of wax worm death at day 1 post-infection. (D) Mean health ± SEM index scores of wax worms at day 1 post-infection.The second mutant tested was the GAS pilus knockout (ΔPilM1) and complemented strain (ΔPilM1+PilM1). Pilus structures are found on the surface of GAS, and have been described to aid in bacterial adherence to the host and in biofilm formation.- Surprisingly, the pilus knockout mutant showed increased virulence compared with the WT, although this did not reach statistical significance (Fig. 6). Bacteria recovered from wax worms infected with ΔPilM1 indicated that replication/survival rate was increased in this mutant as shown by a shift to the left of the in vivo growth kinetic curve compared with WT (). Significantly higher survival rates and health index scores were observed with the complemented strain compared with the knockout mutant (Fig. 6), suggesting that constitutive expression of the pilus reduces virulence. These results were reflected by the LD50 values which were highest for ΔPilM1+PilM1 at 1.2 × 107 CFU, followed by WT at 6 × 106 CFU, and ΔPilM1 at 3.7 × 106 CFU.
Figure 6. Constitutive pilus expression in M1 GAS decreases virulence in the wax worm model. Wax worms were inoculated with a dose titration of WT (circles), pilus knockout (squares), or pilus complemented (triangles) GAS and monitored daily for 5 d. (A) Kaplan-Meier survival curves at an inoculum of 7.5 × 106 CFU/wax worm. *P < 0.05 (log-rank test). (B) Mean ± SEM health index scores of wax worms post-infection with 7.5 × 106 CFU/wax worm. *P < 0.05 (2-way ANOVA). (C) Nonlinear regression of wax worm death at day 1 post-infection. (D) Mean health ± SEM index scores of wax worms at day 1 post-infection.
Figure 6. Constitutive pilus expression in M1 GAS decreases virulence in the wax worm model. Wax worms were inoculated with a dose titration of WT (circles), pilus knockout (squares), or pilus complemented (triangles) GAS and monitored daily for 5 d. (A) Kaplan-Meier survival curves at an inoculum of 7.5 × 106 CFU/wax worm. *P < 0.05 (log-rank test). (B) Mean ± SEM health index scores of wax worms post-infection with 7.5 × 106 CFU/wax worm. *P < 0.05 (2-way ANOVA). (C) Nonlinear regression of wax worm death at day 1 post-infection. (D) Mean health ± SEM index scores of wax worms at day 1 post-infection.
Differential virulence observed from various GAS M-types
To show that multiple strains of GAS can be pathogenic in the wax worm model, eight different strains, each representing a different M-type, were tested. Although it was difficult to compare between M-types because they did not all receive exactly the same dose, it was clear that infection with different M-type strains gave a wide range of responses in the wax worm model (Fig. 7).
Figure 7. Different M-types of GAS are able to infect wax worms to different degrees. (A) Kaplan-Meier survival curves of wax worms over 5 d post-infection with ~1 × 107 CFU GAS. (B) Mean ± SEM health index scores of wax worms over 5 d post-infection with ~1 × 107 CFU GAS.
Figure 7. Different M-types of GAS are able to infect wax worms to different degrees. (A) Kaplan-Meier survival curves of wax worms over 5 d post-infection with ~1 × 107 CFU GAS. (B) Mean ± SEM health index scores of wax worms over 5 d post-infection with ~1 × 107 CFU GAS.
Discussion
The use of wax worms for modeling bacterial infections in vivo has been investigated for a number of pathogens. However, only one study thus far has investigated the use of wax worms for modeling GAS in vivo. In this study we provide further evidence toward the validity of the wax worm model by testing different GAS serotypes and investigating the effect of a number of environmental factors on infection. The additional use of the health index scoring system also enabled measurement of some of the more subtle differences that are often observed during wax worm infection. Health index scores from a very early stage post-infection correlated well with infectious dose, with higher inoculums resulting in lower health index scores. Day 1 health index scores could therefore be used as a predictor of the overall outcome of infection without the need to monitor wax worms for extended periods of time.One surprising finding was that stationary phase cultures of GAS were more pathogenic than exponential phase cultures of GAS, with use of stationary phase cultures resulting in a ~3-fold lower LD50 (Fig. 1C). While this difference was not large, it suggests that virulence factors expressed during the later stage of bacteria growth may be more deliterious to wax worms than those expressed during exponential phase. It is known that many virulence factors are differentially expressed during different growth phases of GAS.- Those involved in immune evasion, adherence, and internalization, for example the M-protein, are more highly expressed during exponential phase of growth to aid in host colonization. Conversely, during stationary growth, factors involved in local tissue destruction and bacterial spreading, for example the cysteine protease SpeB, are upregulated. The increase in virulence at the stationary growth phase may therefore reflect the greater impact of these later-expressed genes on wax worms. This difference in virulence may also be dependent on the route of infection as the “colonization” stage is somewhat bypassed by injecting the bacteria directly into the hemocoel. Because secreted virulence factors are often upregulated during the stationary phase of GAS growth, supernatants from either exponential phase or stationary phase cultures were injected directly into wax worms to test for toxicity. Results showed that a secreted, heat-labile factor active during stationary phase was indeed involved in toxicity to wax worms. However, we cannot exclude the possibility that this factor was also produced during exponential phase, but had simply not accumulated in the supernatant to high enough levels to be toxic.When maintained at 37 °C post-inoculation, bacterial burden increased within the wax worm over time and reaches a plateau at ~1 × 109 CFU (Fig. 3). This appears to be a critical value for the GAS strain that causes death of a wax worm, as CFUs recovered from dead wax worms regardless of the inoculum dose or time of death were always approximately 1 × 109 CFU (Fig. 3).The effect of incubation temperature was also investigated in this study, as one of the benefits the wax worm model has over other insect models is their ability to survive at human body temperatures. A minor delay in wax worm death was observed with some inoculums when wax worms were maintained at a lower temperature (28 °C) post-infection (Fig. 4), as one might expect due to the growth disadvantage of the bacteria at this temperature. However, we cannot exclude the possibility that known differences in temperature-dependent virulence factor expression may have caused this delay.Attenuated virulence mutants of M1 GAS can be monitored in the wax worm model. In this study we show that the M-protein knockout mutant had reduced virulence compared with the WT strain, with virulence being restored with the complemented strain (Fig. 5). These results are consistent with experiments using a mouse model of GAS infection., However, these results contrast those published by Olsen et al. who suggested that an M-protein mutation may not be as important in wax worms as it is in mammals due to the lack of expression of specific mammalian targets in the wax worm. However, this suggestion was based on the lack of correlation between the LD50 values in mice vs. wax worms of a M3-carrier strain that had a natural deletion of the N-terminal region of the M-protein. The authors did not however exclude the possibility that there were other virulence factors that were also differentially expressed in this strain that may have caused the increased virulence in wax worms compared with those observed in mice. Another possibility is that the small 195 bp deletion of the M-protein found in this M3-carrier strain affected the function of the M3 protein in a different way from a complete knockout.Interestingly, the pilus knockout mutant had an opposing effect, showing increased virulence compared with the complemented strain (Fig. 6). One explanation might be because pilus proteins are often expressed early on during infection to aid in colonization, but are subsequently downregulated to promote bacterial spread. Having a constitutively expressed pilus in the complemented strain may have prevented bacterial spreading and therefore reduced virulence in this model. A similar effect was observed in a murine model of infection using a knockout mutant of the major pilus protein. The authors of this study showed that the enhanced virulence observed in mice with the major pilus protein knockout was due to the prevention of neutrophil entrapment.To confirm that multiple serotypes of GAS were pathogenic in the wax worm model, we tested an additional 7 M-types of GAS (originating from patients with a range of diseases from uncomplicated pharyngitis to severe invasive disease) and observed a wide variation in responses (Fig. 7). This confirmed that multiple M-types were able to cause infection in wax worms, but did not show any correlation between virulence in wax worms and severity of disease in humans from which the samples were taken. Correlations between virulence in wax worms and human disease will however require far larger libraries of GAS strains to be tested. Of note is that the M3 strain used in this study was the same reference strain used in the study by Olsen et al., MGAS315. MGAS315 was clearly less pathogenic in our study (Fig. 7) compared with the previously published LD50 of below 105 CFU for this strain. Although more of the same strains need to be tested in different labs to draw meaningful conclusions, this highlights the potential differences either in wax worms provided by different suppliers, environmental, or experimental conditions. In a recent publication, Banville et al. showed that nutritional deprivation led to a reduction in immune response and an increased susceptibility to infection. This does not explain the differences between our study and that conducted by Olsen et al. as both our wax worms were starved post-infection. However, there were other differences including equilibration at different temperatures pre-inoculation. Additional inconsistencies may also arise from wax worms coming from different suppliers such as the type of food, use of antibiotics, natural flora, or genetic make-up. While the wax worm model is unable to fully recapitulate GAS pathogenesis in humans, we have shown that it can provide a useful and cost-effective tool to answer certain questions. As more research groups begin to use wax worms as a model for infection, we also highlight the need for more information about wax worm supply, and further investigation on the effects of different experimental conditions on susceptibility to infection.
Materials and Methods
Bacterial strains and cultures
WT reference strains for each of the 8 M-types used in this study are described in Table 1. Unless otherwise stated, GAS strains were prepared by culturing in brain heart infusion media (BHI) at 37 °C under static conditions until reaching an optical density at 600 nm (OD600) of 0.4–0.6. Media was then removed and bacteria resuspended in phosphate buffered saline (PBS) containing 10% glycerol at an OD600 equivalent to 10. Aliquots were stored at −80 °C until required. When using fresh cultures, bacteria were cultured overnight at 37 °C (for stationary phase) or diluted 1/10 the next day and incubated at 37 °C until OD600 = 0.4–0.6 (for exponential phase cultures). Prior to all inoculations, bacteria were washed once with PBS, and then diluted to the required concentration with PBS before injection. The infecting dose was confirmed for each experiment by serial dilution and colony counting. Kanamycin (200 µg/ml) or spectinomycin (100 µg/ml) was added to growth media where required.
Table 1. GAS strains used in this study
M-type
Strain
Isolation site/infection type
References
M1
SF370
Infected wound
ATCC 700294Suvorov et al.53
M2
MGAS 10270
Pharyngeal swab
BAA-1063Beres et al.54
M3
MGAS315
Toxic-shock-like syndrome patient
BAA-595Musser et al.55
M4
MGAS10750
Pharyngeal swab of pharyngitis patient
BAA-1066Beres et al.54
M6
MGAS10394
Pharyngeal swab
BAA-946Martin et al.56
M18
MGAS8232
Acute rheumatic fever patient
BAA-572Smoot et al.57
M28
MGAS6180
Blood of invasive disease patient)
BAA-1064Green et al.58
M49
57G
Endometriosis patient
Clinical isolate(unpublished)
Generation of knockout and complemented strains
The M-protein knockout strain (ΔM1) was generated by gene-replacement using the plasmid pFW11. Flanking regions of the emm1 gene of GASSF370 were amplified using spyM1_2018 FR1 F/R and spyM1_2018 FR2 F/R primer pairs. PCR products were cloned into pFW11 at MCS-1 and MCS-2 flanking the spectinomycin resistance (aad9) gene, and the construct electroporated into GASSF370. Knockout mutants were selected by spectinomycin resistance and confirmed by PCR using gene-specific primer pairs spyM1_2018r F/R and aad9F/spyM1_2018 FR2R (). The ΔM1 mutant was complemented by re-introducing the emm1 gene in the pLZ12-Km2 plasmid (ΔM1+M1). Briefly, the full length emm1 gene was amplified using the spyM1_2018 FL F/R primer pair and cloned into the EcoRI-BamHI sites of pLZ12-Km2. This construct was then electroporated into the ΔM1 mutant, screened by kanamycin resistance, and confirmed by PCR using the gene-specific primer pairs spyM1_2018r F/R and aad9.fw/spyM1_2018 FR2R ().The pilus knockout (ΔPilM1) and the pilus complemented strains (ΔPilM1 + PilM1) were generated in a similar way using the primer pairs spyM1_0125 FR1 F/R, spyM1_0130 FR2 F/R, and PilM_Bam fw/rev. Presence or absence of the pilus operon was confirmed by PCR using gene-specific primers spy0128 fw/rev and aad9.fw/spyM1_0130 FR2R (). Pilus expression was phenotypically confirmed by western blot of cell wall extracts using polyclonal rabbit IgG against spy0128 as described elsewhere.The spectinomycin-resistant mutant of SF370 was generated by gene replacement of the non-essential sugar phosphate isomerase spy0535 using the primer pairs spyM1_0535 FR1 F/R and spyM1_0535 FR2 F/R.All primers used are listed in Table 2.
Table 2. PCR primers
Primer name
Sequence 5′→3′
spyM1_2018 FR1F
GGATCCATGA CCAATTAGAA ATCGG
spyM1_2018 FR1R
ACTAGTTCTTGAAAGTGACACTCAG
spyM1_2018 FR2F
CTGCAGTGTTATGGCAACAGCTGG
spyM1_2018 FR2R
ACTAGTTTGAGGAGTATGTTGCGG
spyM1_2018 FLF
CTAGGAATTCCTAAAAAATGATAGCATAAGGAGC
spyM1_2018 FLR
CTAGGGATCCAAGAGAGAACCGACTGGTTC
spyM1_2018rF
CTAGGGATCCAACGGTGATGGTAATCCTAGG
spyM1_2018rR
CTAGGAATTCCTGTCTCTTAGTTTCCTTCATTGG
spyM1_0125 FR1F
GTCGACAGTTTCGATAATATCATGGC
spyM1_0125 FR1R
AGATCTATTAAGCTTATTTGGAAACC
spyM1_0130 FR2F
CTGCAGAAATAGATTCAATTTTAAGCAG
spyM1_0130 FR2R
ACTAGTTCTTGAAAGTGACACTCAG
PilM_Bam.fw
GCGGATCCGATATGATGTCACATTGAGAG
PilM_Bam.rev
GCGGATCCGTCGTGGGGCAATAAAAAATTC
Spy0128.fw
CGGGATCCGCTACAACAGTTCACGG
Spy0128.rev
CGGAATTCTTATTCAAAGACTTTTTTATTTG
aad9.fw
AGAGAATATTGAATGGAC
Restriction sites are in bold.
Restriction sites are in bold.
Infection of Galleria mellonella larvae
Galleria mellonella larvae were purchased from Biosuppliers, maintained at room temperature in the dark with food, and used within 2 weeks. As the normal supply of larvae were supplemented with tetracycline in their feed, which prevented their infection by GAS (data not shown), a special supply of antibiotic-free larvae was purchased. Larvae weighed between 100 and 150 mg at time of inoculation. Ten larvae per group were each injected with 20 µl of inoculum into the lower left proleg using an insulin syringe. Each group of 10 insects were incubated at 37 °C in 9 cm petri dishes without food for up to 5 d unless otherwise specified.
Monitoring of Galleria mellonella larvae
Post-infection, Galleria mellonella larvae were monitored daily for the following attributes: Activity, extent of silk production (cocoon formation), melanization, and survival. A score was provided for each attribute that contributed toward an overall health index of an individual wax worm (Wiles, unpublished). A healthy, uninfected wax worm typically scores between 9 and 10, and an infected, dead wax worm typically scores 0. Scoring for each attribute has been summarized in Table 3. Where relevant, wax worms were suspended in 0.5 ml PBS and homogenized by mechanical disruption. Serial dilution and plating of the homogenate onto horse blood agar or BHI agar with or without spectinomycin (100 µg/ml) or kanamycin (200 µg/ml) where appropriate, was performed to determine the bacterial burden per wax worm.
Authors: J M Musser; A R Hauser; M H Kim; P M Schlievert; K Nelson; R K Selander Journal: Proc Natl Acad Sci U S A Date: 1991-04-01 Impact factor: 11.205
Authors: James M Regeimbal; Anna C Jacobs; Brendan W Corey; Matthew S Henry; Mitchell G Thompson; Rebecca L Pavlicek; Javier Quinones; Ryan M Hannah; Meron Ghebremedhin; Nicole J Crane; Daniel V Zurawski; Nimfa C Teneza-Mora; Biswajit Biswas; Eric R Hall Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191
Authors: Lívia M A Figueiredo-Godoi; Maíra T Garcia; Juliana G Pinto; Juliana Ferreira-Strixino; Eliseu Gabriel Faustino; Lara Luise Castro Pedroso; Juliana C Junqueira Journal: Antibiotics (Basel) Date: 2022-05-04
Authors: Gudrun Koch; Charlotte Wermser; Ivan C Acosta; Lara Kricks; Stephanie T Stengel; Ana Yepes; Daniel Lopez Journal: Cell Chem Biol Date: 2017-06-29 Impact factor: 8.116